$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$48.48M
Market Cap
-
P/E Ratio
-0.37
EPS
$5.40
52 Week High
$1.12
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Telomir Pharmaceuticals, Inc. (Ticker: TELO) is a pre-clinical-stage biopharmaceutical company headquartered in Baltimore, Maryland, specializing in the development of innovative therapies for human stem cell disorders. Leveraging proprietary technologies, Telomir is committed to creating novel treatments that may significantly enhance health outcomes in the field of regenerative medicine. With a robust focus on research and development, the company seeks to establish itself as a leader in stem cell therapy, addressing substantial unmet medical needs while creating long-term value for its stakeholders as it transitions toward commercialization.
LPTX
CGC
NVDA
WOK
PLUG
ASST
TSLA
KIND
AVGO
TLRY
KAVL
INTC
TNYA
ADAP
ORCL
SOFI
PLTD
DNN
F
RR
APLT
PFE
PLTR
AAL
IRBT
BYND
WULF
NFLX
MARA
ASBP
BITF
IREN
MTSR
RKLB
KVUE
FI
AMD
HOOD
QBTS
SNAP
BAC
VALE
CIFR
T
IVP
WBD
GOOGL
GRAB
SOUN
CLSK
SMR
BTBT
NOK
CAN
HPE
CDE
NIO
RIG
DVLT
CMG
MU
APLD
HL
AG
IBRX
LPTX
CGC
NVDA
WOK
PLUG
ASST
TSLA
KIND
AVGO
TLRY
KAVL
INTC
TNYA
ADAP
ORCL
SOFI
PLTD
DNN
F
RR
APLT
PFE
PLTR
AAL
IRBT
BYND
WULF
NFLX
MARA
ASBP
BITF
IREN
MTSR
RKLB
KVUE
FI
AMD
HOOD
QBTS
SNAP
BAC
VALE
CIFR
T
IVP
WBD
GOOGL
GRAB
SOUN
CLSK
SMR
BTBT
NOK
CAN
HPE
CDE
NIO
RIG
DVLT
CMG
MU
APLD
HL
AG
IBRX